Skip Navigation


Occupational Medicine Advance Access originally published online on March 30, 2009
Occupational Medicine 2009 59(4):264-266; doi:10.1093/occmed/kqp046
This Article
Right arrow Full Text
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
59/4/264    most recent
kqp046v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Add to My Personal Archive
Right arrow Download to citation manager
Right arrowRequest Permissions
Right arrow Disclaimer
Google Scholar
Right arrow Articles by Sorahan, T.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Sorahan, T.
Social Bookmarking
Add to CiteULike   Add to Connotea   Add to Del.icio.us  
What's this?

© The Author 2009. Published by Oxford University Press on behalf of the Society of Occupational Medicine. All rights reserved. For Permissions, please email: journals.permissions@oxfordjournals.org

Short Reports

Lung cancer mortality in arsenic-exposed workers from a cadmium recovery plant

Tom Sorahan

Institute of Occupational and Environmental Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK

Background There is evidence that arsenic is a late-stage human lung carcinogen.

Aims To investigate lung cancer risks in a cohort of cadmium recovery workers in relation to period from ceasing exposure to arsenic.

Methods The mortality experience (1940–2001) of a cohort of 625 male workers from a US cadmium recovery plant was compared with expectations based on US national mortality rates.

Results There was a statistically significant (P < 0.05) negative trend in lung cancer standardized mortality ratios in relation to period from ceasing arsenic exposure.

Conclusions The findings are consistent with the hypothesis that arsenic is a late-stage human carcinogen.

Keywords      Arsenic; cadmium; cohort study; lung cancer

Correspondence to: Tom Sorahan, Institute of Occupational and Environmental Medicine, University of Birmingham, Edgbaston, Birmingham B15 2TT, UK. Tel: +44 121 414 3644; fax: +44 121 414 6217; e-mail: t.m.Sorahan{at}bham.ac.uk


Add to CiteULike CiteULike   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us    What's this?




Disclaimer: Please note that abstracts for content published before 1996 were created through digital scanning and may therefore not exactly replicate the text of the original print issues. All efforts have been made to ensure accuracy, but the Publisher will not be held responsible for any remaining inaccuracies. If you require any further clarification, please contact our Customer Services Department.